SelfAcademic

SelfAcademic is a biotechnology company focused on the development and commercialization of self-assembling peptide (SAP) technology. The company's platform is based on pioneering research from the Massachusetts Institute of Technology (MIT), specifically the work of Dr. Shuguang Zhang, involving peptides that spontaneously form stable nanofiber scaffolds. These synthetic scaffolds mimic the natural extracellular matrix, providing a biocompatible environment for cell growth, tissue regeneration, and hemostasis. SelfAcademic's technology has been utilized to develop clinical products such as PuraMatrix, a synthetic matrix used in surgery and wound care. The company continues to explore applications of its SAP platform in controlled drug delivery and regenerative medicine.